Skip to main content

Table 1 CD36 data at the different time points analyzed in this study

From: CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes

Glucose concentration

Incubation time

0 h

0.5 h

1 h

2 h

4 h

8 h

16 h

24 h

48 h

Normalized CD36 (CD36 mRNA expression/18s rRNA)

 Control: saline (0 mg/dL)

1.80

1.86

1.84

1.67

1.81

1.79

1.89

2.90

4.00

 EU conditions: 5.5 mM (95 mg/dL)

1.80

4.14

0.76

1.08

1.01

2.05

3.06

4.40

7.39

 HG conditions: 26 mM (498 mg/dL)

1.80

3.28

0.96

1.60

32.8

3.57

1.78

15.6

4.19

Arbitrary non-glycated CD36 protein concentration levels

 Control: saline (0 mg/dL)

–

–

–

–

–

7.70

8.95

–

6.37

 EU conditions: 5.5 mM (95 mg/dL)

–

–

–

–

–

7.20

8.31

–

13.39

 HG conditions: 26 mM (498 mg/dL)

–

–

–

–

–

6.33

1.92

–

6.65

Arbitrary glycated CD36 protein concentration levels

 Control: saline (0 mg/dL)

–

–

–

–

–

14.70

12.43

–

13.99

 EU conditions: 5.5 mM (95 mg/dL)

–

–

–

–

–

10.20

11.89

–

5.59

 HG conditions: 26 mM (498 mg/dL)

–

–

–

–

–

3.77

3.14

–

3.17